Login / Signup

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study.

Qian GengHua ShenWenyu ZhuYingzhi LuMengjie WangHua JiangDongqing Li
Published in: OncoTargets and therapy (2020)
Low-dose apatinib monotherapy might be an option for patients with advanced lung squamous-cell carcinoma.
Keyphrases
  • squamous cell carcinoma
  • low dose
  • combination therapy
  • open label
  • lymph node metastasis
  • locally advanced
  • high dose
  • randomized controlled trial
  • clinical trial
  • radiation therapy
  • rectal cancer